The experimental basis for the choice of an anti-arrhythmic drug.
D000109:Acetylcholine / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy* / Q000209:etiology; D001949:Bretylium Compounds / Q000494:pharmacology; D002395:Catecholamines / Q000494:pharmacology; D006321:Heart / Q000187:drug effects; D006329:Heart Conduction System / Q000502:physiology; D006801:Humans; D000860:Hypoxia / Q000503:physiopathology; D009206:Myocardium / Q000378:metabolism; D009431:Neural Conduction; D011188:Potassium / Q000378:metabolism; D012964:Sodium / Q000378:metabolism; D013961:Thyroid Gland / Q000502:physiology; D013965:Thyroidectomy
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D001949:Bretylium Compounds; D002395:Catecholamines; D012964:Sodium; D000109:Acetylcholine; D011188:Potassium